Compare Torrent Pharma with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ALEMBIC PHARMA - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA ALEMBIC PHARMA TORRENT PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 54.3 15.3 356.0% View Chart
P/BV x 6.5 3.8 171.6% View Chart
Dividend Yield % 0.8 1.0 78.4%  

Financials

 TORRENT PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
ALEMBIC PHARMA
Mar-19
TORRENT PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,550664 233.4%   
Low Rs1,144412 277.3%   
Sales per share (Unadj.) Rs354.7208.7 169.9%  
Earnings per share (Unadj.) Rs40.131.0 129.3%  
Cash flow per share (Unadj.) Rs64.237.1 173.1%  
Dividends per share (Unadj.) Rs14.005.50 254.5%  
Dividend yield (eoy) %1.01.0 101.7%  
Book value per share (Unadj.) Rs273.1144.2 189.4%  
Shares outstanding (eoy) m169.22188.52 89.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.82.6 147.2%   
Avg P/E ratio x33.617.4 193.6%  
P/CF ratio (eoy) x21.014.5 144.6%  
Price / Book Value ratio x4.93.7 132.1%  
Dividend payout %34.917.7 196.9%   
Avg Mkt Cap Rs m227,897101,461 224.6%   
No. of employees `00014.7NA-   
Total wages/salary Rs m11,3537,467 152.0%   
Avg. sales/employee Rs Th4,083.0NM-  
Avg. wages/employee Rs Th772.3NM-  
Avg. net profit/employee Rs Th461.3NM-  
INCOME DATA
Net Sales Rs m60,02139,347 152.5%  
Other income Rs m2,98894 3,185.9%   
Total revenues Rs m63,00939,441 159.8%   
Gross profit Rs m13,4938,736 154.5%  
Depreciation Rs m4,0861,152 354.6%   
Interest Rs m3,085184 1,675.6%   
Profit before tax Rs m9,3107,493 124.2%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5291,568 161.3%   
Profit after tax Rs m6,7815,844 116.0%  
Gross profit margin %22.522.2 101.3%  
Effective tax rate %27.220.9 129.8%   
Net profit margin %11.314.9 76.1%  
BALANCE SHEET DATA
Current assets Rs m52,62319,577 268.8%   
Current liabilities Rs m52,02214,896 349.2%   
Net working cap to sales %1.011.9 8.4%  
Current ratio x1.01.3 77.0%  
Inventory Days Days12090 133.3%  
Debtors Days Days7645 168.1%  
Net fixed assets Rs m85,01627,097 313.7%   
Share capital Rs m846377 224.5%   
"Free" reserves Rs m45,37626,811 169.2%   
Net worth Rs m46,22227,188 170.0%   
Long term debt Rs m41,1154,993 823.4%   
Total assets Rs m142,43247,778 298.1%  
Interest coverage x4.041.7 9.6%   
Debt to equity ratio x0.90.2 484.4%  
Sales to assets ratio x0.40.8 51.2%   
Return on assets %6.912.6 54.9%  
Return on equity %14.721.5 68.3%  
Return on capital %14.223.6 60.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m14,58019,453 75.0%   
Fx outflow Rs m3,6006,065 59.4%   
Net fx Rs m10,98013,388 82.0%   
CASH FLOW
From Operations Rs m8,9428,120 110.1%  
From Investments Rs m-47,070-7,556 622.9%  
From Financial Activity Rs m34,174590 5,788.3%  
Net Cashflow Rs m-3,6551,153 -316.9%  

Share Holding

Indian Promoters % 71.5 74.1 96.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 2.9 242.1%  
FIIs % 12.6 9.1 138.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 13.9 63.3%  
Shareholders   26,511 49,328 53.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  AUROBINDO PHARMA  

Compare TORRENT PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Nov 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS